STEVE D HAGAN

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner LAWRENCEBURG, TN NPI 1568048890

General Payments — all program years on this page

$719.64

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 42
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $382.73 across 22 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $382.7322

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $31.672
2022 $48.073
2023 $257.1715
2024 $382.7322

Records — PY2024 (22)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086299254 Bayer Healthcare Pharmaceuticals Inc. $22.17 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100316248 Novo Nordisk Inc $24.71 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100373485 Novo Nordisk Inc $14.40 03/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100578142 Novo Nordisk Inc $13.74 01/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104536457 AstraZeneca Pharmaceuticals LP $14.04 04/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105491835 AstraZeneca Pharmaceuticals LP $14.62 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107271331 ABBVIE INC. $19.89 04/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107271333 ABBVIE INC. $14.67 05/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107271335 ABBVIE INC. $15.45 06/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1107271337 ABBVIE INC. $18.42 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114440028 Exact Sciences Corporation $14.51 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114440031 Exact Sciences Corporation $17.83 11/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116567865 GlaxoSmithKline, LLC. $13.64 08/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116962761 Medtronic, Inc. $23.38 02/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116962763 Medtronic, Inc. $19.56 04/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116962765 Medtronic, Inc. $25.11 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116962767 Medtronic, Inc. $19.56 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135915709 Lilly USA, LLC $16.00 07/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135915711 Lilly USA, LLC $16.00 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135955457 Lilly USA, LLC $14.66 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1135955459 Lilly USA, LLC $16.00 05/01/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139521520 Astellas Pharma US Inc $14.37 08/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.